28
Oct
2025

OneSource Specialty Pharma Limited

Exhibitor at CPHI Frankfurt 2025 stand 6.1B10, Contract Manufacturing and Services
About Us

We are OneSource. The multimodal specialty pharma CDMO with end-to-end capabilities across tech platforms and therapeutic modalities.

With three decades of experience in specialized drug development and manufacturing, we are able to consistently deliver comprehensive solutions efficiently and effectively across various technology platforms and therapeutic modalities.

Our team of over 1,200 professionals, including more than 200 techno-commercial experts has one goal – to work closely with our partners and make their vision come to life.

  • IN
  • 2024
    On CPHI since
  • 5
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Primary activities
API Producer
Biopharmaceutical
Contract Manufacturer
Generic APIs producer
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Contact info
  • Star 1, Opp IIM Bangalore,, Bilekahalli, Bannerghatta Road, Bangalore,, 560076, Bangalore, India
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 6.1B10, Contract Manufacturing and Services

Products Featured at CPHI Frankfurt 2025

  • Drug-device combinations

    Product Drug-device combinations

    Deep technical expertise spanning device conceptualization, drug-device evaluation, assembly process, cGMP supplies and testing

    Capability to assemble and test multiple pens /autoinjector devices from different device manufacturers, offering great flexibility


    Manufacturing excellence wit...
  • Complex injectables

    Product Complex injectables

    25+ years of experience in complex formulation development, including ready to-use specialty products and novel drug delivery systems

    Proven expertise in niche and complex dosage formats (single and dual-chamber bag, Lyo-vials, PFS, cartridges) to address hospital needs and improve patient experienc...
  • Biologics

    Product Biologics

    End-to-end development and manufacturing capabilities across different therapeutic modalities and the entire product lifecycle

    Cutting-edge technology platforms for high yielding cell lines (both mammalian and microbial) and high concentration formulations


    Integrated and flexible drug sub...